Literature DB >> 26451335

Respondent-Driven Sampling of Heterosexuals at Increased Risk of HIV Infection.

Neale Batra1, Simone C Gray1, Nevin Krishna1, Nikhil Prachand2, William T Robinson3, Cyprian Wejnert1.   

Abstract

Entities:  

Year:  2014        PMID： 26451335      PMCID： PMC4593762     

Source DB:  PubMed          Journal:  Surv Pract


× No keyword cloud information.
  6 in total

1.  Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues.

Authors:  Jichuan Wang; Russel S Falck; Linna Li; Ahmmed Rahman; Robert G Carlson
Journal:  Addict Behav       Date:  2006-08-09       Impact factor: 3.913

2.  Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.

Authors:  Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Keith Sabin; Kathleen Gallagher; Don C Des Jarlais
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

3.  Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil.

Authors:  Lidiane Toledo; Cláudia T Codeço; Neilane Bertoni; Elizabeth Albuquerque; Monica Malta; Francisco I Bastos
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

4.  Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice.

Authors:  Abby E Rudolph; Natalie D Crawford; Carl Latkin; Robert Heimer; Ebele O Benjamin; Kandice C Jones; Crystal M Fuller
Journal:  Ann Epidemiol       Date:  2011-04       Impact factor: 3.797

5.  Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System.

Authors:  Kathleen M Gallagher; Patrick S Sullivan; Amy Lansky; Ida M Onorato
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

6.  Respondent-driven sampling as Markov chain Monte Carlo.

Authors:  Sharad Goel; Matthew J Salganik
Journal:  Stat Med       Date:  2009-07-30       Impact factor: 2.373
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.